COSCIENS Biopharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCOSCIENS Biopharma

COSCIENS Biopharma(CSCI)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Macrilen	Macimorelin	2017-12-20	2027	—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

wasting syndrome

,

,

,

pituitary dwarfism

,

diabetes insipidus

,

,

primary myelofibrosis

,

,

small cell lung carcinoma

,

migraine disorders

,

non-hodgkin lymphoma

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

burkitt lymphoma

Aglatimagene besadenovec

prostatic neoplasms

,

endocrine system diseases

,

smoking cessation

,

,

metabolic bone diseases

,

alcohol-related disorders

,

,

,

,

,

,

,

bulimia nervosa

,

alcohol drinking

,

major depressive disorder

,

addictive behavior

,

,

chronic renal insufficiency

,

kidney diseases

,

pancreatic neoplasms

,

peripheral arterial disease

,

,

abdominal obesity

,

traumatic brain injuries

,

brain concussion

,

peripheral vascular diseases

,

parkinson disease

,

magnetic resonance imaging

,

wasting syndrome

,

,

ischemic stroke

,

,

insulin resistance

,

diabetes mellitus

,

,

,

prader-willi syndrome

,

,

,

,

type 1 diabetes mellitus

,

,

,

,

,

type 2 diabetes mellitus

,

healthy volunteers/patients

,

,

feeding and eating disorders

,

,

binge-eating disorder

,

critical illness

,

bariatric surgery

,

feeding behavior

,

appetitive behavior

,

anorexia nervosa

,

pediatric obesity

,

stomach neoplasms

,

,

polycystic ovary syndrome

,

metabolic syndrome

,

sleep deprivation

,

,

,

satiety response

,

,

,

esophageal neoplasms

,

,

nutrition disorders

,

prediabetic state

,

,

non-alcoholic fatty liver disease

,

,

cardiovascular diseases

,

metabolic diseases

,

hypopituitarism

,

,

cognitive dysfunction

,

cognition disorders

,

neurocognitive disorders

,

,

,

diabetes insipidus

,

,

,

sleep wake disorders

,

circadian rhythm sleep disorders

,

metabolically benign obesity

,

sedentary behavior

,

,

,

,

multiple endocrine neoplasia type 1

,

,

glucose intolerance

,

psychotic disorders

,

heart disease risk factors

,

premature birth

,

,

genetic predisposition to disease

,

obstructive sleep apnea

,

sleep apnea syndromes

,

,

nutritional and metabolic diseases

,

,

,

female infertility

,

,

,

liver cirrhosis

,

hepatocellular carcinoma

,

liver neoplasms

,

,

failure to thrive

,

,

precocious puberty

,

intellectual disability

,

,

fragile x syndrome

,

angelman syndrome

,

smith-magenis syndrome

,

protein c deficiency

,

breast neoplasms

,

,

mental disorders

,

attention deficit and disruptive behavior disorders

,

problem behavior

,

cardiac surgical procedures

,

therapeutic chemoembolization

,

helicobacter infections

,

pregnancy in obesity

,

esophageal diseases

,

endometrial neoplasms

,

,

cystic fibrosis

,

,

glucose metabolism disorders

,

,

glycemic control

,

appetite regulation

,

pregnancy complications

,

fetal growth retardation

,

diastolic heart failure

,

,

,

stress fractures

,

relative energy deficiency in sport

,

,

,

hashimoto disease

,

,

gestational diabetes

,

gastroesophageal reflux

,

immunomodulation

,

,

neuroimmunomodulation

Calcium dobesilate

castration-resistant prostatic neoplasms

,

non-hodgkin lymphoma

,

colorectal neoplasms

,

multiple myeloma

,

,

plasma cell neoplasms

,

prostatic neoplasms

,

,

,

,

drug-related side effects and adverse reactions

,

chronic obstructive pulmonary disease

,

,

obstructive lung diseases

pheochromocytoma

,

,

neuroendocrine tumors

,

pancreatic neoplasms

,

stomach neoplasms

,

intestinal neoplasms

postherpetic neuralgia

Zoptarelin doxorubicin

breast neoplasms

,

prostatic neoplasms

,

urologic neoplasms

,

urinary bladder neoplasms

,

transitional cell carcinoma

,

ureteral neoplasms

,

ovarian neoplasms

,

endometrial neoplasms

delayed puberty

,

duchenne muscular dystrophy

,

growth disorders

,

,

failure to thrive

,

,

,

insulin resistance

,

Globulin, immune

prostatic neoplasms

,

chronic obstructive pulmonary disease

,

,

chronic bronchitis

,

,

,

graft vs host disease

renal cell carcinoma

,

,

non-small-cell lung carcinoma

,

endometrial neoplasms

,

hepatocellular carcinoma

,

stomach neoplasms

,

,

liver neoplasms

,

,

gastrointestinal neoplasms

,

neuroendocrine tumors

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

glucose metabolism disorders

,

metabolic diseases

,

endocrine system diseases

,

breast neoplasms

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use